US Nutritionals Market Q3 Results: Herbalife, Abbott, ChromaDex, USANA, Mannatech
Executive Summary
Herbalife’s five sales regions leaving behind pandemic impact at different speeds; Abbott’s 15.5% nutritional sales growth didn’t overcome more than 30% slump in diagnostics sales; ChromaDex steady sales growth for most of past three years continues with 14% in latest quarter; USANA and Mannatech results slump.
You may also be interested in...
Abbott Speaks Lingo Wearables For Future Growth, Posts Formula As Current Consumer Sales Driver
Lingo’s target “is to do something that not a lot of well-established health care companies do, which is to create a product that's really targeting a healthy population and a healthy population that wants to stay healthy,” says CEO Robert Ford.
Following 6.3% Q1 Sales Slump, Herbalife Expects To Ride North America To Turnaround
Direct seller declines to provide guidance due to dynamic macroeconomic environment but expects a return to growth by end of year led by North America.
US FDA’s Infant Formula Regulatory Authority Doesn’t Reach ‘All That Needs To Be Fixed’
“This system is fundamentally prone to supply chain disruptions with so few manufacturers,” says Mark Moorman, FDA Office of Food Safety director. In FDLI presentation, he acknowledges delicate balance in stemming distribution of potentially contaminated power formula while sustaining supply.